NEUROGESX INC (NGSX)

Overview Price 0.80 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 4 - SELL Open Price $0.00 Previous Close $0.80 Daily Range $0.00 - $0.00 52-Week Range $0.66 - $5.80 Volume 0 NEUROGESX INC., is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over other pain therapies. Other Resources for NGSX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. NEUROGESX INC., is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over other pain therapies.   Brokerage Analyst Recommendations 4 Brokerage Firms Covering NGSX   Strong Buy 2 Buy 0 Hold 2 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2   NGSX Ratings: BUY  SELL  HOLD NGSX Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
zantriocom	0.00	11/17/09	Zantrio.com Free Daily Stock Picks 11-17-09	0
Zacks_Analysts	0.00	11/17/09	NeurogesX Wins Big Approval - Analyst Blog	0
Zacks_Analysts	0.00	06/22/09	NeurogesX Partners Qutenza - Analyst Blog	0

Commentary

BUY: NEUROGESX INC. (NGSX) Start Price: $5.98 Points: -78.70 Created: 01/01/2008 Comments: 0 | Comment MikeStovall Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
MikeStovall	9.46	BUY	Six Months to a Year	01/01/2008	$5.98	$0.80 (-1.17%)	-86.62%	-7.92%	-78.70